vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and Venus Concept Inc. (VERO). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $13.8M, roughly 1.4× Venus Concept Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -163.8%, a 144.1% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -8.2%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-4.9M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs -12.8%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Venus Concept Inc is a global medical technology firm specializing in the development, manufacturing, and distribution of non-invasive and minimally invasive aesthetic medical devices. Its product portfolio covers hair removal, skin rejuvenation, body contouring, and anti-aging solutions, serving dermatology clinics, plastic surgery centers, and medical spas across North America, Europe, and Asia Pacific markets.

CURI vs VERO — Head-to-Head

Bigger by revenue
CURI
CURI
1.4× larger
CURI
$19.2M
$13.8M
VERO
Growing faster (revenue YoY)
CURI
CURI
+44.0% gap
CURI
35.8%
-8.2%
VERO
Higher net margin
CURI
CURI
144.1% more per $
CURI
-19.7%
-163.8%
VERO
More free cash flow
CURI
CURI
$8.9M more FCF
CURI
$3.9M
$-4.9M
VERO
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
-12.8%
VERO

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CURI
CURI
VERO
VERO
Revenue
$19.2M
$13.8M
Net Profit
$-3.8M
$-22.6M
Gross Margin
64.0%
Operating Margin
-17.6%
-68.9%
Net Margin
-19.7%
-163.8%
Revenue YoY
35.8%
-8.2%
Net Profit YoY
-34.6%
-143.0%
EPS (diluted)
$-0.07
$-12.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
VERO
VERO
Q4 25
$19.2M
Q3 25
$18.4M
$13.8M
Q2 25
$19.0M
$15.7M
Q1 25
$15.1M
$13.6M
Q4 24
$14.1M
$15.8M
Q3 24
$12.6M
$15.0M
Q2 24
$12.4M
$16.6M
Q1 24
$12.0M
$17.5M
Net Profit
CURI
CURI
VERO
VERO
Q4 25
$-3.8M
Q3 25
$-3.7M
$-22.6M
Q2 25
$784.0K
$-11.7M
Q1 25
$319.0K
$-12.4M
Q4 24
$-2.8M
$-8.0M
Q3 24
$-3.1M
$-9.3M
Q2 24
$-2.0M
$-20.0M
Q1 24
$-5.0M
$-9.8M
Gross Margin
CURI
CURI
VERO
VERO
Q4 25
Q3 25
64.0%
Q2 25
60.1%
Q1 25
64.2%
Q4 24
69.1%
Q3 24
66.1%
Q2 24
71.5%
Q1 24
66.6%
Operating Margin
CURI
CURI
VERO
VERO
Q4 25
-17.6%
Q3 25
-24.5%
-68.9%
Q2 25
2.5%
-57.6%
Q1 25
0.5%
-69.8%
Q4 24
-27.4%
-42.3%
Q3 24
-25.8%
-47.7%
Q2 24
-20.6%
-33.7%
Q1 24
-30.4%
-44.4%
Net Margin
CURI
CURI
VERO
VERO
Q4 25
-19.7%
Q3 25
-20.4%
-163.8%
Q2 25
4.1%
-74.7%
Q1 25
2.1%
-90.6%
Q4 24
-19.9%
-50.5%
Q3 24
-24.3%
-61.9%
Q2 24
-16.4%
-120.3%
Q1 24
-42.0%
-56.0%
EPS (diluted)
CURI
CURI
VERO
VERO
Q4 25
$-0.07
Q3 25
$-0.06
$-12.14
Q2 25
$0.01
$-8.03
Q1 25
$0.01
$-17.44
Q4 24
$-0.05
$-10.26
Q3 24
$-0.06
$-13.10
Q2 24
$-0.04
$-30.93
Q1 24
$-0.09
$-16.92

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
VERO
VERO
Cash + ST InvestmentsLiquidity on hand
$27.3M
$4.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$2.7M
Total Assets
$75.7M
$61.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
VERO
VERO
Q4 25
$27.3M
Q3 25
$27.8M
$4.3M
Q2 25
$28.1M
$3.9M
Q1 25
$33.4M
$3.2M
Q4 24
$32.1M
$4.3M
Q3 24
$33.2M
$4.5M
Q2 24
$39.5M
$5.7M
Q1 24
$38.8M
$5.1M
Stockholders' Equity
CURI
CURI
VERO
VERO
Q4 25
$41.5M
Q3 25
$47.2M
$2.7M
Q2 25
$49.8M
$2.3M
Q1 25
$58.1M
$2.3M
Q4 24
$57.8M
$2.4M
Q3 24
$62.2M
$10.1M
Q2 24
$64.8M
$3.7M
Q1 24
$67.0M
$-22.5M
Total Assets
CURI
CURI
VERO
VERO
Q4 25
$75.7M
Q3 25
$74.7M
$61.6M
Q2 25
$78.7M
$63.1M
Q1 25
$85.3M
$63.5M
Q4 24
$86.2M
$68.2M
Q3 24
$87.6M
$72.3M
Q2 24
$90.9M
$79.8M
Q1 24
$94.6M
$85.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
VERO
VERO
Operating Cash FlowLast quarter
$4.0M
$-4.9M
Free Cash FlowOCF − Capex
$3.9M
$-4.9M
FCF MarginFCF / Revenue
20.5%
-35.6%
Capex IntensityCapex / Revenue
0.1%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-20.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
VERO
VERO
Q4 25
$4.0M
Q3 25
$4.4M
$-4.9M
Q2 25
$2.8M
$-5.4M
Q1 25
$1.9M
$-6.3M
Q4 24
$3.0M
$-3.8M
Q3 24
$2.3M
$-3.0M
Q2 24
$2.2M
$-1.3M
Q1 24
$666.0K
$-2.9M
Free Cash Flow
CURI
CURI
VERO
VERO
Q4 25
$3.9M
Q3 25
$-4.9M
Q2 25
$-5.6M
Q1 25
$1.8M
$-6.3M
Q4 24
$-3.9M
Q3 24
$-3.1M
Q2 24
$-1.4M
Q1 24
$-2.9M
FCF Margin
CURI
CURI
VERO
VERO
Q4 25
20.5%
Q3 25
-35.6%
Q2 25
-35.8%
Q1 25
12.2%
-46.5%
Q4 24
-24.7%
Q3 24
-20.3%
Q2 24
-8.2%
Q1 24
-16.6%
Capex Intensity
CURI
CURI
VERO
VERO
Q4 25
0.1%
Q3 25
0.0%
0.1%
Q2 25
0.0%
1.0%
Q1 25
0.5%
0.3%
Q4 24
0.0%
0.5%
Q3 24
0.0%
0.0%
Q2 24
0.0%
0.1%
Q1 24
0.0%
0.1%
Cash Conversion
CURI
CURI
VERO
VERO
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURI
CURI

Segment breakdown not available.

VERO
VERO

Products And Services$10.8M79%
Leases$2.9M21%

Related Comparisons